Spliceosome mutations, such as SF3B1 and U2AF1, induce the expression of IRAK4, leading to a targetable, longer, oncogenic IRAK4 isoform in MDS/AML [109,110,111]. The gene discussed is IRAK4; the disease is myelodysplastic syndrome.